Multimodality Imaging for Radiosurgical Management of Arteriovenous Malformations

Authors

  • Ferrat Dincoglan
  • Omer Sager Associate Professor of Radiation Oncology University of Health Sciences, Gulhane Medical Faculty, Department of Radiation Oncology. Gn.Tevfik SaÄŸlam Cd. Etlik , Ankara
  • Seluck Demiral
  • Murat Beyzadeoglu

DOI:

https://doi.org/10.24203/ajpnms.v7i1.5661

Keywords:

stereotactic radiosurgery (SRS), arteriovenous malformation (AVM), target volume

Abstract

Background: Cerebral arteriovenous malformations (AVMs) are rarely seen congenital vascular anomalies. AVMs may lead to intracranial hemorrages due to disorganized tangle of vessels. Lifetime risk of bleeding from AVMs may be significant given the diagnosis at typically earlier ages of the lifespan, and complications associated with hemorrhage may lead to substantial morbidity or mortality. Management of AVMs aims at eliminating or reducing the risk of subsequent bleeding. In this context, microvascular surgical resection, endovascular embolization and radiosurgical treatment may be used for management of AVMs.

Objective: In this study, we assessed the incorporation of Magnetic Resonance Imaging (MRI) in treatment planning for AVM radiosurgery. 

Methods: We identified 25 patients receiving radiosurgery for AVMs at our institution. Radiosurgery target volumes generated by using CT-only based imaging and CT-MR fusion based imaging for each patient were evaluated.

Results: Twenty five patients undergoing SRS for AVMs were evaluated for target volume determination in this study. Mean target volume was 4.9 cc (range: 1.3-15.9 cc) on CT-only imaging, 5.7 cc (range: 1.4-16.7 cc) on CT-MR fusion based imaging, and 5.9 cc (range: 1.4-16.9 cc) on consensus decision of all treating physicians with colleague peer review. Target definition based on CT-MR fusion based imaging was identical to the consensus decision of all treating physicians in majority of patients.

Conclusions: Treatment planning for AVM radiosurgery may be improved by incorporating CT-MR fusion based imaging, which clearly should be supplemented with additional data from angiography. There is need for additional studies to establish a consensus on optimal target definition by multimodality imaging for SRS of AVMs.

References

Halim AX, Johnston SC, Singh V, McCulloch CE, Bennett JP, Achrol AS, Sidney S, Young WL. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke, vol. 35, no. 7, pp. 1697-1702, 2004.

Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet, vol. 359, no. 9309, pp. 863-873, 2002.

Flemming KD, Lanzino G. Management of Unruptured Intracranial Aneurysms and Cerebrovascular Malformations. Continuum (Minneap Minn),vol. 23, no. (1), pp. 181-210, 2017.

Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg, vol. 73, no. 3, pp. 387-391, 1990.

Brown RD Jr, Wiebers DO, Forbes GS. Unruptured intracranial aneurysms and arteriovenous malformations: frequency of intracranial hemorrhage and relationship of lesions. J Neurosurg, vol. 73, no. 6, pp. 859-863, 1990.

Sirin S, Oysul K, Surenkok S, Sager O, Dincoglan F, Dirican B, Beyzadeoglu M. Linear accelerator-based stereotactic radiosurgery in recurrent glioblastoma: a single center experience. Vojnosanit Pregl, vol. 68, no. 11, pp. 961-966, 2011.

Dincoglan F, Beyzadeoglu M, Sager O, Oysul K, Sirin S, Surenkok S, Gamsiz H, Uysal B, Demiral S, Dirican B. Image-guided positioning in intracranial non-invasive stereotactic radiosurgery for the treatment of brain metastasis. Tumori, vol. 98, no. 5, pp. 630-635, 2012.

Dincoglan F, Sager O, Gamsiz H, Demiral S, Uysal B, Surenkok S, Sirin S, Oysul K, Beyzadeoglu M. Management of Arteriovenous Malformations by Stereotactic Radiosurgery: A Single Center Experience. Int J Hematol Oncol, vol. 22, no. 2, pp. 107-112, 2012.

Surenkok S, Sager O, Dincoglan F, Gamsiz H, Demiral S, Uysal B, Sirin S, Oysul K, Beyzadeoglu M. Stereotactic Radiosurgery in Pituitary Adenomas: A Single Center Experience. Int J Hematol Oncol, vol. 22, no. 4, pp. 255-260, 2012.

Dincoglan F, Sager O, Gamsız H, Uysal B, Demiral S, Dirican B, Oysul K, Surenkok S, Sirin S, Beyzadeoglu M. Stereotactic radiosurgery for intracranial tumors: a single center experience. Gulhane Med J, vol. 54, no. 3, pp. 190-198, 2012.

Sager O, Beyzadeoglu M, Dincoglan F, Demiral S, Uysal B, Gamsiz H, Oysul K, Dirican B, Sirin S. Management of vestibular schwannomas with linear accelerator-based stereotactic radiosurgery: a single center experience. Tumori, vol. 99, no. 5, pp. 617-622, 2013.

Demiral S, Beyzadeoglu M, Uysal B, Oysul K, Kahya YE, Sager O, Dincoglan F, Gamsiz H, Dirican B, Surenkok S. Evaluation of stereotactic body radiotherapy (SBRT) boost in the management of endometrial cancer. Neoplasma, vol. 60, no. 3, pp. 322-327, 2013.

Dincoglan F, Beyzadeoglu M, Sager O, Uysal B, Demiral S, Gamsiz H, Dirican B. Evaluation of linear accelerator-based stereotactic radiosurgery in the management of meningiomas: a single center experience. J BUON, vol. 18, no. 3, pp. 717-722, 2013.

Sager O, Beyzadeoglu M, Dincoglan F, Uysal B, Gamsiz H, Demiral S, Oysul K, Dirican B, Sirin S. Evaluation of linear accelerator (LINAC)-based stereotactic radiosurgery (SRS) for cerebral cavernous malformations: a 15-year single-center experience. Ann Saudi Med, vol. 34, no. 1, pp. 54-58, 2014.

Sager O, Beyzadeoglu M, Dincoglan F, Gamsiz H, Demiral S, Uysal B, Oysul K, Dirican B, Sirin S. Evaluation of linear accelerator-based stereotactic radiosurgery in the management of glomus jugulare tumors. Tumori, vol. 100, no. 2, pp. 184-188, 2014.

Gamsiz H, Beyzadeoglu M, Sager O, Dincoglan F, Demiral S, Uysal B, Surenkok S, Oysul K, Dirican B. Management of pulmonary oligometastases by stereotactic body radiotherapy. Tumori, vol. 100, no. 2, pp. 179-183, 2014.

Dincoglan F, Sager O, Gamsiz H, Uysal B, Demiral S, Oysul K, Sirin S, Caglan A, Beyzadeoglu M. Management of patients with ≥4 brain metastases using stereotactic radiosurgery boost after whole brain irradiation. Tumori, vol. 100, no. 3, pp. 302-306, 2014.

Demiral S, Beyzadeoglu M, Sager O, Dincoglan F, Gamsiz H, Uysal B, Oysul K, Gundem E, Dirican B, Sirin S. Evaluation of Linear Accelerator (Linac)-Based Stereotactic Radiosurgery (Srs) for the Treatment of Craniopharyngiomas. Int J Hematol Oncol, vol. 24, no. 2, pp. 123-129, 2014.

Gamsiz H, Beyzadeoglu M, Sager O, Demiral S, Dincoglan F, Uysal B, Onal E, Dirican B. Evaluation of stereotactic body radiation therapy in the management of adrenal metastases from non-small cell lung cancer. Tumori, vol. 101, no. 1, pp. 98-103, 2015.

Sager O, Dincoglan F, Beyzadeoglu M. Stereotactic radiosurgery of glomus jugulare tumors: current concepts, recent advances and future perspectives. CNS Oncol, vol. 4, no. 2, pp. 105-114, 2015.

Dincoglan F, Beyzadeoglu M, Sager O, Demiral S, Gamsiz H, Uysal B, Ebruli C, Akin M, Oysul K, Sirin S, Dirican B. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy. Tumori, vol. 101, no. 2, pp. 179-184, 2015.

Demiral S, Dincoglan F, Sager O, Gamsiz H, Uysal B, Gundem E, Elcim Y, Dirican B, Beyzadeoglu M. Hypofractionated stereotactic radiotherapy (HFSRT) for who grade I anterior clinoid meningiomas (ACM). Jpn J Radiol, vol. 34, no. 11, pp. 730-737, 2016.

Dincoglan F, Sager O, Demiral S, Uysal B, Gamsiz H, Dirican B, Beyzadeoglu M. Radiosurgery for recurrent glioblastoma: a review article. Neurol Disord Therap, vol.1, no. 4, pp. 1-5, 2017.

Demiral S, Dincoglan F, Sager O, Uysal B, Gamsiz H, Ozcan F, Dirican B, Beyzadeoglu M. Contemporary Management of Meningiomas with Radiosurgery. Int J Radiol Imaging Technol, vol. 4, pp. 041, 2018.

Colombo F, Pozza F, Chierego G, Casentini L, De Luca G, Francescon P. Linear accelerator radiosurgery of cerebral arteriovenous malformations: an update. Neurosurgery, vol. 34, no. 1, pp. 14-20, 1994.

Ding D, Starke RM, Kano H, Mathieu D, Huang P, Kondziolka D, Feliciano C, Rodriguez-Mercado R, Almodovar L, Grills IS, Silva D, Abbassy M, Missios S, Barnett GH, Lunsford LD, Sheehan JP. Radiosurgery for Cerebral Arteriovenous Malformations in A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA)-Eligible Patients: A Multicenter Study. Stroke, vol. 47, no. 2, pp. 342-349, 2016.

Cenzato M, Boccardi E, Beghi E, Vajkoczy P, Szikora I, Motti E, Regli L, Raabe A, Eliava S, Gruber A, Meling TR, Niemela M, Pasqualin A, Golanov A, Karlsson B, Kemeny A, Liscak R, Lippitz B, Radatz M, La Camera A, Chapot R, Islak C, Spelle L, Debernardi A, Agostoni E, Revay M, Morgan MK. European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH). Acta Neurochir (Wien), vol. 159, no. 6, pp. 1059-1064, 2017.

Sirin S, Kondziolka D, Niranjan A, Flickinger JC, Maitz AH, Lunsford LD. Prospective staged volume radiosurgery for large arteriovenous malformations: indications and outcomes in otherwise untreatable patients. Neurosurgery, vol. 62, Suppl. 2, pp. 744-754, 2008.

Seymour ZA, Sneed PK, Gupta N, Lawton MT, Molinaro AM, Young W, Dowd CF, Halbach VV, Higashida RT, McDermott MW. Volume-staged radiosurgery for large arteriovenous malformations: an evolving paradigm. J Neurosurg, vol. 124, no. 1, pp. 163-174, 2016.

Pollock BE, Link MJ, Stafford SL, Lanzino G, Garces YI, Foote RL. Volume-Staged Stereotactic Radiosurgery for Intracranial Arteriovenous Malformations: Outcomes Based on an 18-Year Experience. Neurosurgery, vol. 80, no. 4, pp. 543-550, 2017.

Meneghelli P, Pasqualin A, Zampieri P, Longhi M, Foroni R, Sini A, Tommasi N, Nicolato A. Surgical Management of Adverse Radiation Effects After Gamma Knife Radiosurgery for Cerebral Arteriovenous Malformations: A Population-Based Cohort Study. World Neurosurg, vol. 114, pp. e840-e850, 2018.

Monaco EA 3rd, Niranjan A, Kano H, Flickinger JC, Kondziolka D, Lunsford LD. Management of adverse radiation effects after radiosurgery for arteriovenous malformations. Prog Neurol Surg, vol. 27, pp. 108-118, 2013.

Pollock BE, Gorman DA, Coffey RJ. Patient outcomes after arteriovenous malformation radiosurgical management: results based on a 5- to 14-year follow-up study. Neurosurgery, vol. 52, no. 6, pp. 1291-1296, discussion 1296-1297, 2003.

Wang YC, Huang YC, Chen HC, Wei KC, Chang CN, Lee ST, Wu CT, Tseng CK, Wang CC, Chen YL, Hsu PW. Linear accelerator stereotactic radiosurgery in the management of intracranial arteriovenous malformations: long-term outcome. Cerebrovasc Dis, vol. 37, no. 5, pp. 342-349, 2014.

Park CK, Choi SK, Lee SH, Choi MK, Lim YJ. Clinical outcomes and radiosurgical considerations for pediatric arteriovenous malformation: influence of clinical features on obliteration rate. Childs Nerv Syst, vol. 33, no. 12, pp. 2137-2145, 2017.

Stahl JM, Chi YY, Friedman WA. Repeat radiosurgery for intracranial arteriovenous malformations. Neurosurgery, vol. 70, no. 1, pp. 150-154, discussion 154, 2012.

Pollock BE, Kondziolka D, Lunsford LD, Bissonette D, Flickinger JC. Repeat stereotactic radiosurgery of arteriovenous malformations: factors associated with incomplete obliteration. Neurosurgery, vol. 38, no. 2, pp. 318-324, 1996.

Pollock BE, Flickinger JC, Lunsford LD, Maitz A, Kondziolka D. Factors associated with successful arteriovenous malformation radiosurgery. Neurosurgery, vol. 42, no. 6, pp. 1239-1244, 1998.

Ellis TL, Friedman WA, Bova FJ, Kubilis PS, Buatti JM. Analysis of treatment failure after radiosurgery for arteriovenous malformations. J Neurosurg, vol. 89, no. 1, pp. 104-110, 1998.

Yen CP, Sheehan JP, Schwyzer L, Schlesinger D. Hemorrhage risk of cerebral arteriovenous malformations before and during the latency period after GAMMA knife radiosurgery. Stroke, vol. 42, no. 6, pp. 1691-1696, 2011.

Zabel-du Bois A, Milker-Zabel S, Huber P, Schlegel W, Debus J. Risk of hemorrhage and obliteration rates of LINAC-based radiosurgery for cerebral arteriovenous malformations treated after prior partial embolization. Int J Radiat Oncol Biol Phys, vol. 68, no. 4, pp. 999-1003, 2007.

Shin M, Kawahara N, Maruyama K, Tago M, Ueki K, Kirino T. Risk of hemorrhage from an arteriovenous malformation confirmed to have been obliterated on angiography after stereotactic radiosurgery. J Neurosurg, vol. 102, no. 5, pp. 842-846, 2005.

Maruyama K, Kawahara N, Shin M, Tago M, Kishimoto J, Kurita H, Kawamoto S, Morita A, Kirino T. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med, vol. 352, no. 2, pp. 146-153, 2005.

Yen CP, Schlesinger D, Sheehan JP. Natural history of cerebral arteriovenous malformations and the risk of hemorrhage after radiosurgery. Prog Neurol Surg, vol. 27, pp. 5-21, 2013.

Downloads

Published

2019-02-18

How to Cite

Dincoglan, F., Sager, O., Demiral, S., & Beyzadeoglu, M. (2019). Multimodality Imaging for Radiosurgical Management of Arteriovenous Malformations. Asian Journal of Pharmacy, Nursing and Medical Sciences, 7(1). https://doi.org/10.24203/ajpnms.v7i1.5661

Issue

Vol. 7 No. 1 (2019): February 2019

Section

Articles

License

  • Papers must be submitted on the understanding that they have not been published elsewhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and are not currently under consideration by another journal published by any other publisher.
  • It is also the authors responsibility to ensure that the articles emanating from a particular source are submitted with the necessary approval.
  • The authors warrant that the paper is original and that he/she is the author of the paper, except for material that is clearly identified as to its original source, with permission notices from the copyright owners where required.
  • The authors ensure that all the references carefully and they are accurate in the text as well as in the list of references (and vice versa).
  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
  • The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.